Blue Trust’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Blue Trust's BEAM Position: Q3 2026 in Review
Blue Trust opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 4 shares worth $98. The stake represents ﹤0.01% of the portfolio and ranks #2427 among its holdings. This is a return to the name: Blue Trust previously reported a position in BEAM as recently as Q3 2025.
Blue Trust first reported a position in BEAM in Q2 2022 and has held it in 14 quarters since. The position peaked at $73.5K in Q3 2024. 196 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Blue Trust held 4 shares of Beam Therapeutics worth $98 as of Q3 2026.
- Beam Therapeutics was a new Blue Trust position in Q3 2026.
- Beam Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2427 holding.
- Blue Trust first reported a position in Beam Therapeutics in Q2 2022 and has held it in 14 quarters since.
- Blue Trust's Beam Therapeutics position peaked at $73.5K in Q3 2024.
- 196 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.